
1. malar j. 2020 jul 31;19(1):275. doi: 10.1186/s12936-020-03345-y.

use nat-based assay improve surveillance system prevent
transfusion-transmitted malaria blood banks.

rocha d(1)(2), de melo gc(3)(4), carneiro jmh(5), ribeiro m(1)(2), ribeiro s(1), 
de godoy dt(1), costa e(1), de almeida acg(3), de andrade ef(1)(2), abrahim
cmm(5), fraiji na(5), ferreira agp(1), monteiro wm(3)(4), brindeiro r(2), tanuri 
a(2), de lacerda mvg(3)(4)(6), alvarez p(7).

author information: 
(1)institute technology immunobiology bio-manguinhos, oswaldo cruz
foundation/fiocruz, avenida brasil 4365, rio de janeiro, brazil.
(2)departamento de genética, universidade federal rio de janeiro-ufrj, rio de 
janeiro, brazil.
(3)instituto de pesquisa clínica carlos borborema, fundação de medicina tropical 
heitor vieira dourado, manaus, amazonas, brazil.
(4)universidade estado amazonas, manaus, amazonas, brazil.
(5)hemoam-fundação hospitalar de hematologia e hemoterapia amazonas, manaus,
amazonas, brazil.
(6)instituto de pesquisas leônidas e maria deane, fiocruz, manaus, amazonas,
brazil.
(7)institute technology immunobiology bio-manguinhos, oswaldo cruz
foundation/fiocruz, avenida brasil 4365, rio de janeiro, brazil.
palvarez@bio.fiocruz.br.

erratum in
    malar j. 2020 sep 4;19(1):325.

background: malaria transmitted blood transfusion donations
collected asymptomatic donors. transfusion-transmitted malaria (ttm) poses a
great risk blood services worldwide. good screening tool plasmodium spp.
detection blood banks must high sensitivity prevention ttm.
however, brazilian blood banks, screening malaria still relies on
microscopy.
methods: brazil, screening human immunodeficiency virus type 1 (hiv),
rna/dna hepatitis c (hcv) hepatitis b (hbv) viruses mandatory for
every blood donation uses nucleic acid amplification testing (nat). aim
of study evaluate inclusion assay malaria identify
plasmodium sp. total nucleic acid (tna; dna/rna) targeting 18s rrna
gene parasite.
results: considering limitations microscopy wide availability of
the brazilian nat platform screening blood units hiv, hcv, hbv,
a molecular diagnostic tool validated detection plasmodium sp. in
blood banks; pilot study showed using novel nat assay could reduce
the risk ttm.
conclusion: prototype hiv/hcv/hbv/malaria nat assay effective in
detecting infected candidate donors good prospects applied in
routine screening preventing ttm.

doi: 10.1186/s12936-020-03345-y 
pmcid: pmc7395345
pmid: 32736625 

